RIA
IOVA icon

Realta Investment Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Realta Investment Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-31,115
Closed -$854K – 346
2020
Q2 		$854K Buy
31,115
+1,850
+6% +$60.8K 0.28% 90
2020
Q1 		$876K Sell
29,265
-125
-0.4% -$3.31K 0.38% 61
2019
Q4 		$666K Hold
29,390
– – 0.18% 139
2019
Q3 		$534K Buy
29,390
+815
+3% +$18K 0.15% 166
2019
Q2 		$698K Buy
28,575
+10,535
+58% +$159K 0.19% 128
2019
Q1 		$172K Buy
+18,040
New +$175K 0.08% 303

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Realta Investment Advisors's IOVA Position: Q3 2020 in Review

Realta Investment Advisors sold out of Iovance Biotherapeutics (IOVA) in Q3 2020, closing a stake of 31,115 shares — an estimated $854K sold.

Realta Investment Advisors first reported a position in IOVA in Q1 2019 and held it in 6 quarters. The position peaked at $876K in Q1 2020. 252 funds tracked by Wall St. Rank hold IOVA as of Q3 2020.

  • Realta Investment Advisors reported no remaining Iovance Biotherapeutics position as of Q3 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 31,115 Iovance Biotherapeutics shares in Q3 2020, an estimated $854K.
  • Realta Investment Advisors first reported a position in Iovance Biotherapeutics in Q1 2019 and held it in 6 quarters.
  • Realta Investment Advisors's Iovance Biotherapeutics position peaked at $876K in Q1 2020.
  • 252 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2020.

Based on Realta Investment Advisors's 13F filing for Q3 2020, filed 23 Oct 2020.